ストックスクリーナーアプリを入手
129.50
1.42%
1.81
前日終値:
$127.69
開ける：
$128.33
24時間の取引高:
949.57K
Relative Volume:
1.11
時価総額：
$9.78B
収益：
$12.82B
当期純損益:
$936.34M
株価収益率:
12.06
EPS:
10.74
ネットキャッシュフロー:
$1.47B
1週間 パフォーマンス:
-6.48%
1か月 パフォーマンス:
-9.94%
6か月 パフォーマンス:
-25.39%
1年 パフォーマンス:
-6.75%
1日の値動き範囲:
$127.32
$130.51
1週間の範囲:
$126.07
$141.52
52週間の値動き範囲:
$126.07
$179.60
Davita Inc Stock (DVA) Company Profile
DVA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
DVA
Davita Inc
|
129.50 | 9.14B | 12.82B | 936.34M | 1.47B | 10.74 |
|
HCA
Hca Healthcare Inc
|
381.61 | 85.68B | 72.70B | 5.97B | 7.29B | 23.79 |
|
THC
Tenet Healthcare Corp
|
165.58 | 14.07B | 20.52B | 1.46B | 1.41B | 15.12 |
|
FMS
Fresenius Medical Care Ag Adr
|
24.07 | 13.80B | 20.92B | 666.06M | 1.85B | 1.1422 |
|
EHC
Encompass Health Corp
|
117.58 | 11.75B | 5.51B | 494.70M | 386.40M | 4.84 |
|
UHS
Universal Health Services Inc
|
172.30 | 10.53B | 16.08B | 1.20B | 1.06B | 17.82 |
Davita Inc Stock (DVA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-03-06 | 開始されました | Barclays | Equal Weight |
| 2023-08-07 | アップグレード | UBS | Neutral → Buy |
| 2022-11-01 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2022-10-31 | ダウングレード | UBS | Buy → Neutral |
| 2022-08-19 | 再開されました | UBS | Buy |
| 2022-06-21 | 繰り返されました | BofA Securities | Underperform |
| 2021-09-10 | 開始されました | Cowen | Market Perform |
| 2021-08-12 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2021-03-26 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2021-01-05 | ダウングレード | BofA Securities | Buy → Neutral |
| 2020-01-24 | アップグレード | Goldman | Neutral → Buy |
| 2019-11-07 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2019-10-25 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2019-09-11 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2019-07-26 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2019-01-08 | アップグレード | UBS | Sell → Neutral |
| 2019-01-03 | 開始されました | Deutsche Bank | Buy |
| 2018-12-14 | 開始されました | Barclays | Overweight |
| 2018-11-28 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2018-11-16 | 開始されました | UBS | Sell |
| 2018-11-08 | ダウングレード | Raymond James | Strong Buy → Mkt Perform |
| 2018-09-13 | アップグレード | JP Morgan | Underweight → Neutral |
| 2018-01-04 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2017-12-12 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2017-12-11 | アップグレード | Citigroup | Neutral → Buy |
| 2017-12-07 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2017-11-08 | 繰り返されました | RBC Capital Mkts | Sector Perform |
| 2017-10-09 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2017-06-26 | ダウングレード | Jefferies | Buy → Hold |
| 2016-12-13 | ダウングレード | Robert W. Baird | Outperform → Neutral |
すべてを表示
Davita Inc (DVA) 最新ニュース
Can DaVita’s (DVA) Share Buybacks Offset Mixed Q2 Earnings Trends? - simplywall.st
DaVita Inc. (NYSE:DVA) Q2 2025 Earnings Call Transcript - MSN
Barclays Updates DaVita (DVA) with Lower Price Target to $160 | - GuruFocus
DaVita Shares Plunge 9% Amid 150% Volume Surge to $430M, Rank 264th in Market Activity - AInvest
DaVita 2025 Q2 Earnings Net Income Falls 8.2% Despite Revenue Growth - AInvest
DaVita Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
DaVita Stock Down Despite Q2 Earnings Beat, Gross Margin Expands - The Globe and Mail
DaVita Inc. Stock Dives 8.5% on Declining Treatment Volumes and Forecast CutNews and Statistics - IndexBox
Why DaVita (DVA) Stock Is Nosediving - Yahoo Finance
Huge healthcare breach sees nearly a million patients hit following DaVita ransomware attackmake sure you're safe - TechRadar
Barclays Adjusts DaVita Price Target to $160 From $169 - MarketScreener
DaVita stock hits 52-week low at $131.09 amid market fluctuations - Investing.com Nigeria
Over 900K hit by DaVita ransomware hack - SC Media
DaVita 2025 Q2 Earnings Mixed Performance as Net Income Falls 8.2% - AInvest
Deutsche Bank Adjusts DaVita Price Target to $137 From $165, Maintains Hold Rating - MarketScreener
DaVita Inc. Exceeds Expectations with Strong Q2 2025 Revenue GrowthNews and Statistics - IndexBox
DaVita reiterates $2.01B–$2.16B adjusted operating income guidance for 2025 as cost controls offset volume headwinds - MSN
DaVita HealthCare: Q2 Earnings Snapshot - Greenwich Time
DaVita Inc (DVA) Q2 2025 Earnings Call Highlights: Navigating Challenges with Resilience and ... - uk.finance.yahoo.com
DaVita Inc (DVA) Q2 2025 Earnings Call Highlights: Navigating Ch - GuruFocus
DaVita Inc (DVA) Q2 2025 Earnings Call Highlights: Navigating Challenges with Resilience and ... By GuruFocus - Investing.com Canada
DaVita Inc. (DVA) Stock Forecasts - Yahoo Finance
DaVita Inc. (DVA): Mastering Capital Allocation in a High-Margin Dialysis Industry - AInvest
Strategic Cost Management as the Cornerstone of DaVita's Resilient Operational Performance in 2025 - AInvest
Can DaVita's Pattern of Revenue Outperformance Shape Its Broader Growth Narrative? (DVA) - simplywall.st
DaVita Outpaces Expectations Despite Cyberattack And Hurricane Setbacks - Finimize
Earnings call transcript: DaVita Q2 2025 beats estimates, stock dips - Investing.com
DaVita Inc reports results for the quarter ended June 30Earnings Summary - TradingView
DaVita’s (NYSE:DVA) Q2 Sales Beat Estimates - TradingView
DaVita HealthCare (DVA) Q2 Earnings and Revenues Top Estimates - Yahoo Finance
DAVITA INC. SEC 10-Q Report - TradingView
DaVita beats quarterly profit on steady demand for dialysis services - TradingView
DaVita HealthCare Reports Strong Q2 Earnings, Surpassing ExpectationsNews and Statistics - IndexBox
DaVita Inc Q2 2025 Earnings: Revenue Surpasses Estimates at $3.3 - GuruFocus
DaVita Inc. Q2 Sales Increase - Nasdaq
DaVita earnings beat by $0.17, revenue topped estimates By Investing.com - Investing.com South Africa
DaVita earnings beat by $0.17, revenue topped estimates - Investing.com Australia
DaVita Inc Q2 2025 Earnings: Revenue Surpasses Estimates at $3.38 Billion, Adjusted EPS Beats at $2.95 - GuruFocus
DaVita Inc. 2nd Quarter 2025 Results - PR Newswire
Berkshire Hathaway buys $106.5M in Sirius XM, cuts $230M in DaVita - MSN
Dialysis company DaVita says more than 900,000 people affected by April ransomware attack - The Record from Recorded Future News
Investors Aren't Entirely Convinced By DaVita Inc.'s (NYSE:DVA) Earnings - simplywall.st
Berkshire Hathaway Boosts Sirius XM Stake to 37%, Sells DaVita Shares - WebProNews
Warren Buffett's Berkshire Hathaway Offloads $230 Million In DaVita Stock Ahead Of Q2 Earnings - inkl
Berkshire Hathaway Buys More Sirius XM Stock, Sells DaVita Shares in Recent Days - Barron's
Berkshire Hathaway buys $106.5M in Sirius XM, cuts $230M in DaVita (SIRI:NASDAQ) - Seeking Alpha
Insider Transactions Reported | DaVita(DVA)saw insider trading activity on 8/4/2025 - AInvest
Akebia Initiates Vafseo® (vadadustat) Post-Marketing Study in Conjunction with Large Dialysis Organization - Stock Titan
DaVita (DVA) To Report Earnings Tomorrow: Here Is What To Expect - Yahoo Finance
Is DaVita Inc. stock overvalued or undervaluedMaximize returns with strategic trading plans - Jammu Links News
Is DaVita Inc. a good long term investmentBreakout portfolio performance - Jammu Links News
Davita Inc (DVA) 財務データ
収益
当期純利益
現金流量
EPS
1.94%
大文字化:
|
ボリューム (24 時間):